Department of Clinical and Toxicological Analyses, Faculty of Pharmaceutical Sciences, University of São Paulo, São Paulo, Brazil.
Biochem Biophys Res Commun. 2012 Jan 13;417(2):918-23. doi: 10.1016/j.bbrc.2011.12.078. Epub 2011 Dec 22.
The 18 kDa translocator protein (TSPO) also known as the peripheral benzodiazepine receptor (PBR), mediates the transportation of cholesterol and anions from the outer to the inner mitochondrial membrane in different cells types. Although recent evidences indicate a potential role for TSPO in the development of inflammatory processes, the mechanisms involved have not been elucidated. The present study investigated the ability of the specific TSPO ligands, the isoquinoline carboxamide PK11195 and benzodiazepine Ro5-4864, on neutrophil recruitment promoted by the N-formylmethionyl-leucyl-phenylalanine peptide (fMLP), an agonist of G-protein coupled receptor (GPCR). Pre-treatment with Ro5-4864 abrograted fMLP-induced leukocyte-endothelial interactions in mesenteric postcapillary venules in vivo. Moreover, in vitro Ro5-4864 treatment prevented fMLP-induced: (i) L-selectin shedding and overexpression of PECAM-1 on the neutrophil cell surface; (ii) neutrophil chemotaxis and (iii) enhancement of intracellular calcium cations (iCa(+2)). Intriguingly, the two latter effects were augmented by cell treatment with PK11195. An allosteric agonist/antagonist relation may be suggested, as the effects of Ro5-4864 on fMLP-stimulated neutrophils were reverted by simultaneous treatment with PK11195. Taken together, these data highlight TSPO as a modulator of pathways of neutrophil adhesion and locomotion induced by GPCR, connecting TSPO actions and the onset of an innate inflammatory response.
18kDa 转位蛋白(TSPO)也称为外周苯二氮䓬受体(PBR),在不同的细胞类型中介导胆固醇和阴离子从外膜向线粒体内膜的转运。尽管最近的证据表明 TSPO 在炎症过程的发展中可能具有潜在作用,但涉及的机制尚未阐明。本研究调查了特异性 TSPO 配体,异喹啉甲酰胺 PK11195 和苯二氮䓬 Ro5-4864,对 N-甲酰基-甲硫氨酸-亮氨酸-苯丙氨酸肽(fMLP)诱导的中性粒细胞募集的作用,fMLP 是 G 蛋白偶联受体(GPCR)的激动剂。Ro5-4864 预处理可阻断体内肠系膜后腔静脉中 fMLP 诱导的白细胞-内皮相互作用。此外,在体外,Ro5-4864 处理可防止 fMLP 诱导:(i)L-选择素脱落和 PECAM-1 在中性粒细胞表面的过表达;(ii)中性粒细胞趋化性;和(iii)细胞内钙离子(iCa(+2))的增强。有趣的是,后两种作用通过用 PK11195 处理细胞而增强。可以提出变构激动剂/拮抗剂关系,因为 Ro5-4864 对 fMLP 刺激的中性粒细胞的作用可通过同时用 PK11195 处理而逆转。总之,这些数据强调 TSPO 作为 GPCR 诱导的中性粒细胞黏附和迁移途径的调节剂,连接 TSPO 作用和先天炎症反应的发生。